After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
State Department Sanctions Syrian Military Officials for Role in Ghouta Sarin Attack CBRNE October 24, 2022 …
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents CBRNE April 11, 2022 …
CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats CBRNE March 21, 2022 …
4 Essential Reads to Understand Russia’s False Claims About Biological Weapons in Ukraine Biosecurity March 15, 2022 …
OPCW Issues Fact-Finding Report on 2016 Chemical Weapons Incident in Kafr Zeita, Syria CBRNE February 1, 2022 …
“Resurrector” Drugs Have Potential to Rescue Aged AChE to Fight Nerve Agents CBRNE October 17, 2021 …
First-in-Class Nerve Agent Antidote Crosses Blood-Brain Barrier to Aid Central Nervous System CBRNE October 12, 2021 …
Artificial Intelligence Seed Projects Announced at Army’s Chemical Biological Center Defense + Military October 11, 2021 …
Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats CBRNE September 29, 2021 …
DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats CBRNE October 31, 2020 …
State Department: Reducing Revisionist State Biological and Chemical Weapons Threats CBRNE October 27, 2020 …
